1. Agid Y. Parkinson's disease : pathophysiology. Lancet. 1991; 337:1321–1324. PMID:
1674304.
2. Björklund A, Dunnett SB, Stenevi U, Lewis ME, Iversen SD. Reinnervation of the denervated striatum by substantia nigra transplants : functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 1980; 199:307–333. PMID:
7417786.
Article
3. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging. 2007; 34:1583–1593. PMID:
17503039.
Article
4. Dauer W, Przedborski S. Parkinson's disease : mechanisms and models. Neuron. 2003; 39:889–909. PMID:
12971891.
5. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science. 2003; 302:819–822. PMID:
14593166.
Article
6. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992; 55:138–142. PMID:
1538221.
Article
7. Downes JH, Hammond MW, Xydas D, Spencer MC, Becerra VM, Warwick K, et al. Emergence of a small-world functional network in cultured neurons. PLoS Comput Biol. 2012; 8:e1002522. PMID:
22615555.
Article
8. Erdö F, Bührle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab. 2003; 23:780–785. PMID:
12843782.
Article
9. Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci. 2002; 5:627–628. PMID:
12042822.
Article
10. Hedlund E, Perlmann T. Neuronal cell replacement in Parkinson's disease. J Intern Med. 2009; 266:358–371. PMID:
19765180.
Article
11. Hwang O, Baker H, Gross S, Joh TH. Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells. Synapse. 1998; 28:140–153. PMID:
9450514.
Article
12. Bjorklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. 2003; 2:437–445. PMID:
12849125.
Article
13. Kato-Negishi M, Tsuda Y, Onoe H, Takeuchi S. A neurospheroid network-stamping method for neural transplantation to the brain. Biomaterials. 2010; 31:8939–8945. PMID:
20850180.
Article
14. Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998; 39:1521–1530. PMID:
9744335.
15. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A. 2004; 101:11839–11844. PMID:
15280535.
Article
16. Kim JS, Lee JS, Im KC, Kim SJ, Kim SY, Lee DS, et al. Performance measurement of the microPET focus 120 scanner. J Nucl Med. 2007; 48:1527–1535. PMID:
17704248.
Article
17. Kim ST, Choi JH, Chang JW, Kim SW, Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J Neurochem. 2005; 95:89–98. PMID:
16181415.
Article
18. Lei Z, Jiang Y, Li T, Zhu J, Zeng S. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease. J Neuropathol Exp Neurol. 2011; 70:736–747. PMID:
21865882.
Article
19. Lund RD, Hauschka SD. Transplanted neural tissue develops connections with host rat brain. Science. 1976; 193:582–584. PMID:
959815.
Article
20. McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O. Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci Lett. 2002; 326:155–158. PMID:
12095645.
Article
21. Mehta V, Spears J, Mendez I. Neural transplantation in Parkinson's disease. Can J Neurol Sci. 1997; 24:292–301. PMID:
9398975.
Article
22. Nikkhah G, Cunningham MG, Cenci MA, McKay RD, Björklund A. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J Neurosci. 1995; 15(5 Pt 1):3548–3561. PMID:
7538563.
Article
23. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 1996; 19:102–109. PMID:
9054056.
Article
24. Paillé V, Henry V, Lescaudron L, Brachet P, Damier P. Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias. Mov Disord. 2007; 22:533–539. PMID:
17230470.
Article
25. Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, et al. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Neuroscience. 2000; 95:377–388. PMID:
10658617.
Article
26. Rehncrona S. A critical review of the current status and possible developments in brain transplantation. Adv Tech Stand Neurosurg. 1997; 23:3–46. PMID:
9075470.
Article
27. Tabbal S, Fahn S, Frucht S. Fetal tissue transplantation [correction of transplanation] in Parkinson's disease. Curr Opin Neurol. 1998; 11:341–349. PMID:
9725080.
28. Williams LN, Seignourel P, Crucian GP, Okun MS, Rodriguez RL, Skidmore FM, et al. Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease. Mov Disord. 2007; 22:141–145. PMID:
17089386.
Article
29. Yoon HH, Lee CS, Hong SH, Min J, Kim YH, Hwang O, et al. Evaluation of a multiple system atrophy model in rats using multitracer microPET. Acta Neurochir (Wien). 2012; 154:935–940. PMID:
21866326.
Article
30. Yoon HH, Min J, Shin N, Kim YH, Kim JM, Hwang YS, et al. Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson's disease? Neural Regen Res. 2013; 8:1190–1200. PMID:
25206413.
Article